A representative of the WHO Regional Office for Europe told RIA Novosti that the organization expects to receive information on the results of clinical trials of all Russian vaccines against COVID-19.
“Based on the long-standing traditions of the Russian Federation in the production and development of vaccines, we are confident that global testing standards, including the exchange of data with the global community, will be met,” the WHO representative said.
He also expressed gratitude to the Russian authorities for sharing the results of clinical trials of the first vaccine.
Let us remind you that Sputnik V, developed by the Gamaleya Research Center for Electrochemistry with the support of the Russian Direct Investment Fund, was registered on August 11, and on September 9 the post-registration phase of trials began in Russia.
In mid-October, the second domestically produced coronavirus vaccine passed the registration procedure. The drug was developed by the Novosibirsk center "Vector".
Earlier, the World Health Organization noted the quick and timely measures of the Russian authorities in response to the increase in the number of cases of coronavirus.